{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2014-D-1856\" sorted by posted_date descending", "rows": [["FDA-2014-D-1856-0161", "FDA", "FDA-2014-D-1856", "Testimony from Paul Cederna (PSF)", "Other", "Testimony", "2016-10-19T04:00:00Z", 2016, 10, "2016-10-19T04:00:00Z", null, "2016-10-19T21:02:50Z", null, 0, 0, "0900006482278d7b"], ["FDA-2014-D-1856-0159", "FDA", "FDA-2014-D-1856", "Testimony from Scot Glasberg", "Other", "Testimony", "2016-10-19T04:00:00Z", 2016, 10, "2016-10-19T04:00:00Z", null, "2016-10-19T20:36:21Z", null, 0, 0, "0900006482278d79"], ["FDA-2014-D-1856-0153", "FDA", "FDA-2014-D-1856", "Testimony from Rebecca Baergen (Alston & Bird LLP)", "Other", "Testimony", "2016-10-19T04:00:00Z", 2016, 10, "2016-10-19T04:00:00Z", null, "2016-10-19T20:26:05Z", null, 0, 0, "0900006482277bdf"], ["FDA-2014-D-1856-0160", "FDA", "FDA-2014-D-1856", "Testimony from Peter Rubin (ASPS)", "Other", "Testimony", "2016-10-19T04:00:00Z", 2016, 10, "2016-10-19T04:00:00Z", null, "2016-10-19T21:01:36Z", null, 0, 0, "090000648227896a"], ["FDA-2014-D-1856-0087", "FDA", "FDA-2014-D-1856", "Write-In Campaign #2 (Multiple Submitters 13) Form Letter Comment", "Other", "Form Letter", "2016-04-27T04:00:00Z", 2016, 4, "2016-04-27T04:00:00Z", null, "2016-04-27T14:01:02Z", null, 0, 0, "0900006481f67919"], ["FDA-2014-D-1856-0086", "FDA", "FDA-2014-D-1856", "Draft Guidances Relating to the Regulation of Human Cells, Tissues,\nand Cellular and Tissue-Based Products; Extension of Comment Periods", "Proposed Rule", "Extension of Comment Period", "2016-04-22T04:00:00Z", 2016, 4, "2016-04-22T04:00:00Z", "2016-09-28T03:59:59Z", "2016-10-20T01:00:57Z", "2016-09366", 0, 0, "0900006481f83c8e"], ["FDA-2014-D-1856-0083", "FDA", "FDA-2014-D-1856", "Write-In Campaign #1 (Multiple Submitters 17) Form Letter Comment", "Other", "Form Letter", "2016-04-13T04:00:00Z", 2016, 4, "2015-10-30T04:00:00Z", "2016-04-30T03:59:59Z", "2016-04-13T19:47:11Z", null, 0, 0, "0900006481f2eef7"], ["FDA-2014-D-1856-0061", "FDA", "FDA-2014-D-1856", "Human Cells, Tissues, and Cellular and Tissue-Based Products From \nAdipose Tissue: Regulatory Considerations; Draft Guidance for Industry; \nReopening of the Comment Period", "Proposed Rule", "Reopening of Comment Period", "2015-10-30T04:00:00Z", 2015, 10, "2015-10-30T04:00:00Z", "2016-04-30T03:59:59Z", "2024-11-07T23:24:13Z", "2015-27706", 1, 0, "0900006481cfc915"], ["FDA-2014-D-1856-0055", "FDA", "FDA-2014-D-1856", "Request to Extend Comment Period from Association of Organ Procurement Organizations", "Other", "Request for Extension", "2015-02-27T05:00:00Z", 2015, 2, "2015-02-27T05:00:00Z", null, "2015-02-27T20:39:52Z", null, 0, 0, "0900006481a1f1d1"], ["FDA-2014-D-1856-0005", "FDA", "FDA-2014-D-1856", "Reference 2 Brown et al., Basic Science Review on Adipose Tissue for Clinicians re Human Cells Tissues, and Cellular and Tissue Based Products HCTPs From Adipose Tissue: Regulatory Consideration; Draft Guidance for Industry, FDA-2014-D-1856-0002", "Supporting & Related Material", "Background Material", "2014-12-24T05:00:00Z", 2014, 12, null, null, "2015-01-02T15:19:45Z", null, 0, 0, "0900006481991c17"], ["FDA-2014-D-1856-0002", "FDA", "FDA-2014-D-1856", "Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)\nFrom Adipose Tissue: Regulatory Considerations; Draft Guidance for\nIndustry", "Other", "Guidance", "2014-12-24T05:00:00Z", 2014, 12, "2014-12-24T05:00:00Z", null, "2024-11-12T05:31:43Z", null, 1, 0, "0900006481991c12"], ["FDA-2014-D-1856-0004", "FDA", "FDA-2014-D-1856", "Reference 1 Chapter 6 Adipose Tissue re Human Cells Tissues, and Cellular and Tissue Based Products HCTPs From Adipose Tissue: Regulatory Consideration; Draft Guidance for Industry, FDA-2014-D-1856-0002", "Supporting & Related Material", "Background Material", "2014-12-24T05:00:00Z", 2014, 12, null, null, "2015-01-02T15:19:44Z", null, 0, 0, "0900006481991c15"], ["FDA-2014-D-1856-0001", "FDA", "FDA-2014-D-1856", "Human Cells, Tissues, and Cellular and Tissue-Based Products From Adipose Tissue: Regulatory Considerations; Draft Guidance for Industry; Availability", "Proposed Rule", "Request for Comment", "2014-12-24T05:00:00Z", 2014, 12, "2014-12-24T05:00:00Z", "2015-02-24T04:59:59Z", "2015-02-24T03:13:21Z", "2014-30142", 0, 0, "09000064819914d3"], ["FDA-2014-D-1856-0003", "FDA", "FDA-2014-D-1856", "Reference List re Human Cells Tissues, and Cellular and Tissue Based Products HCTPs From Adipose Tissue: Regulatory Consideration; Draft Guidance for Industry, FDA-2014-D-1856-0002", "Supporting & Related Material", "Background Material", "2014-12-24T05:00:00Z", 2014, 12, null, null, "2014-12-24T20:22:25Z", null, 0, 0, "0900006481991c14"]], "truncated": false, "filtered_table_rows_count": 14, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2014-D-1856"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-D-1856", "results": [{"value": "FDA", "label": "FDA", "count": 14, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2014-D-1856", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-D-1856", "results": [{"value": "Other", "label": "Other", "count": 8, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-D-1856&document_type=Other", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-D-1856&document_type=Proposed+Rule", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-D-1856&document_type=Supporting+%26+Related+Material", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-D-1856", "results": [{"value": 2016, "label": 2016, "count": 7, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-D-1856&posted_year=2016", "selected": false}, {"value": 2014, "label": 2014, "count": 5, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-D-1856&posted_year=2014", "selected": false}, {"value": 2015, "label": 2015, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-D-1856&posted_year=2015", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-D-1856&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-D-1856&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-D-1856&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-D-1856&_facet=comment_start_date"}, {"name": "comment_end_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-D-1856&_facet=comment_end_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-D-1856&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-D-1856&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-D-1856&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-D-1856&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-D-1856&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 42.440887074917555, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}